2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice …

FLJ Visseren, F Mach, YM Smulders… - European heart …, 2021‏ - academic.oup.com
Atherosclerotic cardiovascular (CV) disease (ASCVD) incidence and mortality rates are
declining in many countries in Europe, but it is still a major cause of morbidity and mortality …

Apolipoprotein B particles and cardiovascular disease: a narrative review

AD Sniderman, G Thanassoulis, T Glavinovic… - JAMA …, 2019‏ - jamanetwork.com
Importance The conventional model of atherosclerosis presumes that the mass of
cholesterol within very low-density lipoprotein particles, low-density lipoprotein particles …

[HTML][HTML] Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials

C Reith, C Baigent, L Blackwell, J Emberson, E Spata… - The Lancet, 2022‏ - thelancet.com
Background Statin therapy is effective for the prevention of atherosclerotic cardiovascular
disease and is widely prescribed, but there are persisting concerns that statin therapy might …

[HTML][HTML] Профилактика хронических неинфекционных заболеваний в Российской Федерации. Национальное руководство 2022

ОМ Драпкина, АВ Концевая, АМ Калинина… - Кардиоваскулярная …, 2022‏ - cyberleninka.ru
Члены Комитета экспертов подтвердили отсутствие финансовой поддержки/конфликта
интересов. В случае сообщения о наличии конфликта интересов, член (ы) Комитета …

Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2022

T Okamura, K Tsukamoto, H Arai, Y Fujioka… - … of atherosclerosis and …, 2024‏ - jstage.jst.go.jp
In Japan, a super-aged society, deaths from atherosclerotic cardiovascular disease
(ASCVD), especially cardiac diseases including coronary artery disease (CAD) such as …

Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: a multivariable Mendelian randomisation …

TG Richardson, E Sanderson, TM Palmer… - PLoS …, 2020‏ - journals.plos.org
Background Circulating lipoprotein lipids cause coronary heart disease (CHD). However,
the precise way in which one or more lipoprotein lipid-related entities account for this …

Triglyceride-rich lipoprotein remnants, low-density lipoproteins, and risk of coronary heart disease: a UK Biobank study

E Björnson, M Adiels, MR Taskinen… - European Heart …, 2023‏ - academic.oup.com
Aims The strength of the relationship of triglyceride-rich lipoproteins (TRL) with risk of
coronary heart disease (CHD) compared with low-density lipoprotein (LDL) is yet to be …

Deep-learning-based cardiovascular risk stratification using coronary artery calcium scores predicted from retinal photographs

TH Rim, CJ Lee, YC Tham, N Cheung, M Yu… - The Lancet Digital …, 2021‏ - thelancet.com
Background Coronary artery calcium (CAC) score is a clinically validated marker of
cardiovascular disease risk. We developed and validated a novel cardiovascular risk …

Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease

JS Lees, CE Welsh, CA Celis-Morales, D Mackay… - Nature medicine, 2019‏ - nature.com
Chronic kidney disease is common in the general population and associated with excess
cardiovascular disease (CVD), but kidney function does not feature in current CVD risk …

2021 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults

GJ Pearson, G Thanassoulis, TJ Anderson… - Canadian journal of …, 2021‏ - Elsevier
The 2021 guidelines primary panel selected clinically relevant questions and produced
updated recommendations, on the basis of important new findings that have emerged since …